MiMedx Group Inc (MDXG)
Healthcare
Biotechnology
4.30 $
+3.4%
vs. previous close
Closing price · As of: 3. Aug 2026
MiMedx Group Inc (MDXG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -10 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13 | 10 | 6.0 | 22 | 20 | 19 | 5.3 | 14 | 29 | 25 | 1.9 | -10 | 46 | |
| 0.8 | 0.8 | 0.7 | 1.1 | 1.2 | 3.0 | 3.2 | 3.2 | 5.3 | 3.2 | 1.6 | 1.5 | 12 | |
| 4.4 | 4.2 | 4.3 | 4.1 | 3.8 | 4.7 | 4.3 | 4.8 | 4.9 | 2.5 | -1.7 | 0.9 | 6.6 | |
| -1.9 | -10 | -12 | 2.3 | 3.4 | 0.4 | -11 | -4.2 | -6.0 | -1.8 | 15 | -0.2 | 7.5 | |
| 0.6 | 0.4 | 6.1 | 0.4 | 5.2 | 0.3 | 0.4 | 0.2 | 3.9 | 0.4 | 0.6 | 0.7 | 5.6 | |
| -0.6 | -0.5 | -6.0 | -0.9 | 0.1 | -2.8 | -0.4 | -0.9 | -5.3 | -0.3 | -5.6 | -0.6 | -12 | |
| – | 0.6 | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0 | -9.5 | -2.2 | -0.3 | -0.1 | 0.0 | -2.5 | -0.5 | -0.1 | -0.1 | -1.9 | -13 | -15 | |
| – | – | – | – | -0.3 | -0.2 | -0.3 | -0.3 | -0.3 | -0.3 | -0.4 | -0.4 | -1.3 | |
| 0.4 | -8.9 | -33 | -0.4 | 0.0 | -0.4 | -2.9 | -1.1 | -0.9 | -0.6 | -2.6 | -13 | -17 | |
| 13 | 0.8 | -34 | 21 | 20 | 16 | 2.0 | 12 | 23 | 24 | -6.3 | -24 | 17 | |
| 12 | 9.8 | -0.2 | 21 | 14 | 19 | 4.9 | 14 | 25 | 25 | 1.3 | -11 | 41 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.